Bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for c

Bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B

Pivotal B-Well data show a significant 19% functional cure in the overall study population and 26% in patients with lower viral activity.